GE unveils new cardiovascular ultrasound
At this month’s Society of Echocardiography meeting in Chicago, GE Medical Systems showed a new cardiovascular ultrasound system named the Vivid FiVe. GE officials said this is the first ultrasound system on the market to offer a myocardial
At this months Society of Echocardiography meeting in Chicago, GE Medical Systems showed a new cardiovascular ultrasound system named the Vivid FiVe. GE officials said this is the first ultrasound system on the market to offer a myocardial tissue visualization technique called tissue tracking.
The tool aids cardiologists in the diagnosis and monitoring of coronary artery disease.
Vivid FiVe was preceded by the Vingmed System FiVe in GEs line of cardiovascular ultrasound products, and is an upgrade to this system. The Vivid FiVe includes three new features: tissue tracking, contrast imaging with real-time myocardial contrast, and four-dimensional imaging.
Tissue tracking provides more accurate imaging of the heart, contrast imaging allows clinicians to study myocardial perfusion, and 4-D imaging occurs when clinicians apply 2-D digital data to construct a 4-D model of cardiac functions.
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
June 11th 2025Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.
